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humans: A systematic review
Abstract
© The Authors 2020. There is increasing evidence linking the gut microbiota to various aspects of human
health. Nuts are a food rich in prebiotic fibre and polyphenols, food components which have been shown
to have beneficial effects on the gut microbiota. This systematic review aimed to synthesise the evidence
regarding the effect of nut consumption on the human gut microbiota. A systematic search of the
databases MEDLINE, PubMed, Cochrane CENTRAL, and CINAHL was performed until November 28, 2019.
Eligible studies were those that investigated the effects of nut consumption in humans (aged over three
years old), utilising next-generation sequencing technology. Primary outcome measures were betweengroup differences in α- and β-diversity metrics and gut microbial composition. A total of eight studies
were included in the review. Included studies assessed the effects of either almonds, walnuts, hazelnuts
or pistachios on the gut microbiota. Overall, nut consumption had a modest impact on gut microbiota
diversity, with two studies reporting a significant shift in a α-diversity and four reporting a significant shift
in β-diversity. Walnuts, in particular, appeared to more frequently explain shifts in β-diversity, which may
be a result of their unique nutritional composition. Some shifts in bacterial composition (including an
increase in genera capable of producing short-chain fatty acids: Clostridium, Roseburia, Lachnospira and
Dialister) were reported following the consumption of nuts. Nut intake may yield a modulatory effect on
the gut microbiota, however results were inconsistent across studies, which may be explained by
variations in trial design, methodological limitations and inter-individual microbiota.
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Abstract
There is increasing evidence linking the gut microbiota to various aspects of human health. Nuts are a food rich in prebiotic fibre and polyphenols, food components which have been shown to have beneficial effects on the gut microbiota. This systematic review aimed to synthesise
the evidence regarding the effect of nut consumption on the human gut microbiota. A systematic search of the databases MEDLINE, PubMed,
Cochrane CENTRAL and CINAHL was performed until 28 November 2019. Eligible studies were those that investigated the effects of nut consumption in humans (aged over 3 years old), utilising next-generation sequencing technology. Primary outcome measures were between-group
differences in α- and β-diversity metrics and gut microbial composition. A total of eight studies were included in the review. Included studies
assessed the effects of either almonds, walnuts, hazelnuts or pistachios on the gut microbiota. Overall, nut consumption had a modest impact on
gut microbiota diversity, with two studies reporting a significant shift in α-diversity and four reporting a significant shift in β-diversity. Walnuts, in
particular, appeared to more frequently explain shifts in β-diversity, which may be a result of their unique nutritional composition. Some shifts in
bacterial composition (including an increase in genera capable of producing SCFA: Clostridium, Roseburia, Lachnospira and Dialister) were
reported following the consumption of nuts. Nut intake may yield a modulatory effect on the gut microbiota; however, results were inconsistent
across studies, which may be explained by variations in trial design, methodological limitations and inter-individual microbiota.
Key words: Nuts: Gut microbiome: Gut microbiota: Prebiotics: Systematic reviews: DNA sequencing

The gut microbiome is a rapidly expanding area of human
research(1). While often used interchangeably(2), the term gut
‘microbiome’ refers to all of the microbial genes that reside inside
the gastrointestinal tract, while the microbes themselves are collectively known as the ‘microbiota’. Being a complex and metabolically active ecosystem, these microbes generally maintain a
symbiotic relationship with the host and participate in a number
of beneficial functions within the body. These include the synthesis of vitamins(3), regulating the immune system(4) and production of SCFA, which are a key energy source for colonic
epithelial cells(5). Interestingly, several health conditions have
been linked with alterations in the gut microbiota populations,
including type 2 diabetes(6,7), obesity(8,9) and inflammatory
bowel disease(10); however, it is unclear if this dysbiosis is a cause
or consequence of the disease(11).
Relatively recent advancements in techniques used to characterise the composition of the microbiota have provided a greater
understanding of host–gut microbiota metabolic interactions and
its subsequent effect on human physiology. Since 2005,
advancements in microbial determination methods, in particular

Abbreviations: OTU, operational taxonomic unit; UM, urolithin metabotype.
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high-throughput sequencing techniques, have vastly improved
the understanding of the gut microbiota, by allowing a more
comprehensive investigation of phylogenetic composition and
quantification(12). Examples of this technology include the
next-generation sequencing of the 16s rRNA gene or its amplicons, which are based on sequence divergences of the small
subunit rRNA(13).
Given the potential impact of the gut microbiome on human
health and disease, there is a need to identify foods which may
support a healthy microbiome. Previous research has shown that
prebiotic fibres are a key substrate facilitating change in the
microbiome(14). In humans, prebiotic fibre escapes digestion
in the small intestine and instead passes into the colon where
it is used as a substrate by the microbes. Here, it stimulates
the growth of specific organisms leading to the production of different metabolites, including the SCFA butyrate, which confers
health benefits to the host(15).
Nut consumption is associated with many positive health
benefits(16). Both epidemiological studies and clinical trials have
linked frequent nut consumption to a reduced risk of developing

Downloaded from https://www.cambridge.org/core. University of Wollongong, on 15 Sep 2020 at 23:11:01, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114520002925

British Journal of Nutrition, page 1 of 13
© The Author(s), 2020. Published by Cambridge University Press on behalf of The Nutrition Society

E. Fitzgerald et al.

type 2 diabetes(17) and CHD(18), as well as a reduction in cardiovascular risk factors such as hypertension(19) and the promotion
of a more beneficial lipid profile(20). Nuts are nutrient dense and
contain high amounts of plant-based protein, unsaturated fatty
acids, vitamins, minerals and other phytochemicals(21). Nuts
have the second highest fibre content of all foods per 100 g,
behind cereals(22). Nuts are also a food source rich in polymerised polyphenols(23), resistant starch(24) and NSP(25), which
appear to have a prebiotic effect. Additionally, walnuts are particularly high in n-3 fatty acids, with preliminary research classifying these fatty acids as prebiotics(26). While the health benefits
of nuts may in part be due to their unique nutritional composition, the exact mechanism by which nuts exert this range of beneficial health effects remains unclear. Previous trials have
examined the specific microbial shifts that occur with nut consumption(27–34); however, due to inconsistency of study findings,
there is a need to evaluate the evidence base. The present systematic review aimed to synthesise the existing evidence regarding the effect of nut consumption (tree nuts and peanuts) on the
gut microbiota of humans. We hypothesise that due to the array
of prebiotic compounds, supplementation of the diet with nuts
promotes the proliferation of beneficial microbial species, leading to favourable changes in the gut microbiota.

Methods
This systematic review was reported according to the guidelines
of the Preferred Reporting Items for Systematic Reviews and
Meta-Analysis statement(35). The review protocol was prospectively registered in PROSPERO (International Prospective
Register of Systematic Reviews) protocol no. CRD42019127318.

Literature search
A systematic search of the electronic databases MEDLINE
(EBSCO), PubMed, Cochrane CENTRAL and CINAHL (EBSCO)
was performed until 28 November 2019, using a combination
of MeSH and individual search terms. No date or language
restriction was applied in the search strategy. In conjunction with
searching the electronic databases, additional hand searching of
the reference lists of relevant articles was also performed. An
example search strategy is presented in online Supplementary
Data 1.

Study selection
All search results were exported from the electronic databases
into the reference management software ENDNOTE (X9;
Thomson Reuters), and duplicates were then removed.
Eligible studies were identified by two review authors (EF and
EN) who screened articles independently based on title and
abstract. Full texts were then retrieved, and the eligibility criteria
were applied to the full-text articles. Discrepancies were
resolved by consensus or consultation with a third party (KL).
Studies were included if they met all of the following criteria:
(1) human studies involving participants aged more than 3 years
old. This broad age range was used due to findings showing that
the gut microbiota of children resembles that of an adult after
3 years of age(36); (2) nuts were administered in their whole form

or minimally processed to still contain all components of the
whole nut (e.g. nut butters, roasted, ground or chopped nuts);
(3) consumption of nuts was compared with no consumption
of nuts or a lower quantity of nuts; (4) study design was in the
form of randomised or non-randomised experiments, crosssectional or cohort studies and (5) outcomes were measured
using next-generation DNA sequencing technologies, including
both targeted amplicon sequencing and shotgun metagenomics.
Studies were restricted to those that used these methods as they
provide the most comprehensive analysis of the microbiota, enabling taxonomic quantification and identification. Additionally,
limiting to these methods provided a means of promoting homogeneity between study results, considering the range of microbiota characterisation techniques available and the subsequent
differences in reporting of outcome measurements(12).
In addition to the inclusion criteria outlined above, the following exclusion criteria were applied: (1) in vitro experiments
and animal studies due to the limited applicability of these results
to the human microbiota, (2) experiments where nut intake
could not be isolated from other interventions (e.g. other dietary
interventions) and (3) studies which only measured changes in
the microbiota-related metabolites. In addition, studies which
included both nuts in their whole form and isolated nut components (such as oils or extracts) were only included if data from
nuts in their whole form could be differentiated.

Outcome measures
Primary outcome measures were between-group differences in
α- and β-diversities, as well as statistically significant differences
in the taxonomic composition and microbial abundances at specific taxonomic levels (phylum, class, order, family, genus or
‘operational taxonomic units’ (OTU). α-Diversity is a measure
of within-sample (or community) diversity, taking into account
the richness and/or evenness of the microbes present(37).
β-Diversity is a measure of microbial dissimilarity between samples or sites, describing how many taxa are shared between
samples(38).

Data extraction and quality assessment
A tabular summary was developed for the data extraction process, which included the population, study design and duration,
nut type format and dosage, method of microbiota determination
and results. Only significant findings (P < 0·05) from each study
reporting changes in microbial composition following nut intake
were recorded. The quality of included studies was assessed
using the Quality Criteria Checklist and Risk of Bias
Assessment Tool by the Academy of Nutrition and Dietetics(39).

Results
Summary of included studies
Searches of the electronic databases returned 894 articles, of
which fifty-six were evaluated after removal of duplicates and
screening of records. A final eight studies met the eligibility criteria and were included in the present review. The above study
selection process is summarised in the Preferred Reporting Items
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Identification

for Systematic Reviews and Meta-Analysis 2009 Flow Diagram
(Fig. 1) with the included studies summarised in Table 1 and
described below. For all studies, significant shifts (P < 0·05) in
microbial composition following nut intake are summarised in
Table 2.
Five of the eight studies were randomised controlled crossover trials(27,28,31,32,34) with the population group being healthy
adults, one of which also included healthy children(32). All of
these studies utilised a washout period, ranging from 1 to
6 weeks, in between treatment periods. The remaining three
studies consisted of a parallel design randomised controlled
trial(33) and two pre-test/post-test studies(29,30). Studies were predominantly published in the USA(27,31–34) (n 5/8), with one being
published in Germany(28), one in Italy(30) and one in Spain(29).
Sample sizes ranged from n 15 to 194, with the proportion of
female participants in each study ranging from 28 to 83 %.
Feeding periods within studies ranged from 3 d to 8 weeks, with
overall study length ranging from 3 d up to 24 weeks. Three studies examined the effect of whole walnut consumption on the gut
microbiota(27–29), one study utilised whole roasted hazelnuts(30),
three studies(31–33) investigated almonds in varying forms of the
whole nut and one study utilised both whole almonds or
pistachios(34). Nut dose in adult participants varied from

Records identified through
database searching
(n 894)

3

approximately one serving (33 g/d) up to two servings daily
(84 g), with the dosage being adapted for children. In most studies, the rationale for nut dosage was due to this serving size (42 or
43 g, or 1·5 oz) being consistent with the US Food and Drug
Administration qualified health claim for nuts and CVD(40).
All eligible studies assessed the gut microbiota using highthroughput sequencing technology, with all studies sequencing
the 16s rRNA gene to determine bacterial composition. Seven
studies used the Illumina Miseq(27–33), whereas one used 454based pyrosequencing platform(34). In addition, three studies
reported on microbial communities other than bacteria with
one study also sequencing fungal DNA(34) (using primers
directed against the IS4 and IS5 inter-spacer regions), and two
studies sequencing both fungal (ITS1–ITS4) and archaeal (16s
rRNA gene using 349f/806r primers) DNA(27,31). All studies measured α-diversity using one or a combination of indices
(Simpson’s index, Shannon index, Chao-1 index, Faith’s phylogenic diversity or observed OTU). Reported measures of
β-diversity used across included studies were the UniFrac and
Bray-Curtis distance metrics.
Using the Academy of Nutrition and Dietetics Evidence
Analysis Manual Quality Criteria Checklist, six of the eight studies
were deemed to be of positive quality(27,28,30,31,33,34) with the

Additional records identified
through other sources
(n 0)

Eligibility

Screening

Records after duplicates removed
(n 517)

Records screened
(n 517)

Full-text articles assessed
for eligibility
(n 56)

Records excluded
(n 461)

Full-text articles excluded, with
reason
(n 48)
Not possible to isolated the effects of nuts n 7
Conference abstract only n 5

Studies included in
qualitative synthesis
(n 8)

Only measured microbial metabolites n 10
Study protocol only n 11

Included

Included nut extracts n 1
In vitro experiments n 2
Not appropriate study design n 8
Not reporting outcome of interest n 4

Fig. 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram of study selection.
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n 27;
39·5 (SD 7·3)
years (55·5 %)
Participants were
clustered
according to their
UM: UM-A (n 14),
UM-B (n 13)

Garcia-Mantrana
et al.(29) (Spain)

n 18; 53·1 (SEM 2·2)
years (44 %)

n 194; 63 (SEM 0·54)
years (69 %)

(27)

Sample size (n),
mean age (years),
(% female)

Bamberger
et al.(28)
(Germany)

Holscher et al.
(USA)

Reference
(country)

Healthy adults; BMI 23·3
(SD 3·2)

Healthy adults; BMI 25·1
(SEM 4·0)

Healthy adults; BMI 28·8
(SEM 0·9)

Population; BMI (kg/m )

2

Pre-test–post-test
study
Free-living study
Level III-3

RCT-C free-living
trial
Level II

RCT-C feeding trial*
Level II

Study design and
NHMRC level of
evidence

Intervention
period: 3 d

Run-in period:
4 weeks
Intervention
period: 8 weeks
Washout
period: 4 weeks

Run-in period: 9 d
Intervention
period: 3 weeks
Washout period:
1 week

Study duration
and washout
period

Participants taking
antibiotics or pre/
probiotics 2 months
prior to the study
were excluded

Participants on
antibiotic therapy
were excluded (no
time frame given)

NR

Antibiotic/probiotic use

Table 1. Characteristics of included trials examining the effect of nut consumption on the gut microbiota

Walnut, whole nut
33 g/d

Walnut, whole nut
43 g/d

Walnut, whole nut
42 g/d

Nut type and format;
dose (g/d)

Diet recommendations:
Mediterranean diet.
Participants were
advised to restrict
their intake of
ellagitannincontaining foods
Dietary fibre intake (all
participants): mean
26·1 (SD 5·9) g/d,
UM-A: 26·7 (SD
6·4) g/d, UM-B: 25·4
(SD 5·7) g/d

Isoenergetic Westerntype diet (15 %
PRO, 35 % fat,
50 % CHO)
Walnuts substituted for
fat or CHO (or both)
Dietary fibre intake: NS
different between
treatment periods

Isoenergetic standard
American diet:
(17 % PRO, 29 %
fat, 54 % CHO)
Walnuts substituted for
base diet foods
Dietary fibre intake: NR

Diet of participants;
fibre intake

Compliance
assessed via a
questionnaire on
completion of the
study, results NR

Compliance
assessed via
self-reported food
records results
NR
Compliance to the
different diet
types (fat
restriction,
carbohydrate
restriction or
both) with walnut
intake was poor

Compliance
assessed via
daily
questionnaire,
results NR
Supervised feeding
for breakfast and
dinner. Lunch
and weekend
meals provided to
participants and
consumed offsite

Compliance to diet

No control

No nuts

No nuts

Control
group

Self-sampled, stored
at –20°C
overnight and
then stored
at –80°C until
analysis

Self-sampled,
refrigerated for
<24 h before
clinic visit, where
samples were
immediately
frozen (–20°C)
and transported
on dry ice
(–80°C) until
further analysis

Self-sampled; stored
at –80°C

Stool collection,
temp and storage

16s rRNA gene
sequencing
(V3–V4 region)
Illumina Miseq
Taxonomy database
NR

Bacterial (16s rRNA
gene sequencing,
V4 region)
Archaeal (V3–V4
region)
Fungal (ITS1–ITS4)
Illumina Miseq
Taxonomy database:
GreenGenes
(bacterial /
archaeal) and
UNITE OTU ITS
12_11 (fungal)
16s rRNA gene
sequencing
(V3–V4 region)
Illumina Miseq
Taxonomy database
NR

Method of microbiota
determination and
taxonomy database

α-Diversity: NS
(α-diversity test
NR)
β-Diversity:
significant
differences
between groups
(PCoA plot using
weighted UniFrac
distances,
P = 0·03)
(statistical test
NR)
α-Diversity: NS
(Shannon and
Simpson’s
indexes)
β-Diversity reported
significant
differences
between groups
(PERMANOVA
using both
weighted and
unweighted
UniFrac metrics,
P = 0·02)
Compared with
baseline, αDiversity:
significantly
decreased for
UM-A (P = 0·024)
and UM-B
(P < 0·001)
(Chao-1 index)
β-Diversity:
significant
differences
between time
periods for all
individuals (T0–
T3) (P < 0·01),
however when
stratified by UM,
significant
differences were
only observed for
UM-B (P = 0·017)
(PERMANOVA
based on BrayCurtis, nonphylogenic)

Diversity metrics
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n 15† with
hyperlipidaemia,
11 (range 7–17)
years

n 18, 56·7 (SD 10·2)
years (44 %)

n 29 child–parent
pairs. Adults: 35
(SE 0·6) years
(83 %), children:
4 (SE 0·2) years
(48 %)

Holscher et al.(31)
(USA)

Burns et al.(32)
(USA)

Sample size (n),
mean age (years),
(% female)

Gargari et al.(30)
(Italy)

Reference
(country)

Table 1. (Continued )

RCT-C
Feeding trial
Level II

RCT-C
Free-living trial
Level II

Healthy adults (BMI < 18·5
to >30) and children

Pre-test/post-test
study
Free-living trial
Level III-3

Study design and
NHMRC level of
evidence

Healthy adults, BMI 29·7
(SD 4·4)

Children and adolescents
with primary
hyperlipidaemia, with
diagnosed familial
hypercholesterolaemia,
familial combined
hyperlipidaemia, or
polygenic
hypercholesterolaemia
BMI NR

Population; BMI (kg/m )

2

Run-in period:
1 week
Intervention
period: 3 weeks
Washout
period: 6 weeks

Run-in period: 9 d
Intervention
period: 3 weeks
Washout
period: 1 week

Intervention
period: 8 weeks

Study duration
and washout
period

Participants on
antibiotic therapy in
previous 2 months
were excluded

NR

Participants on
antibiotic therapy or
probiotics/prebiotics
in previous 1 month
excluded

Antibiotic/probiotic use

Almonds (whole raw or
almond butter
equivalent)
Adults: 43 g/d (1·5 oz)
Children: 14 g/d
(0·5 oz)

Almonds, varying
forms (whole raw,
whole dry roasted,
chopped dry
roasted and dry
roasted almond
butter)
42 g/d

Hazelnuts, roasted
whole with skin
0·43 g of hazelnuts
per d per kg of body
weight, up to a
maximum of 30 g

Nut type and format;
dose (g/d)

Diet recommendations
NR
Dietary fibre intake:
mean 2·6 g/1000 kJ
(children),
2·5 g/1000 kJ
(adults). NS change
during treatment
periods

Recommendations for
paediatric
hyperlipidaemia
based on the
Cardiovascular
Health Integrated
Lifestyle Diet(72)
(15 % PRO, 30 %
fat, 55 % CHO,
10–25 g/d soluble
fibre and <300 mg/d
dietary cholesterol)
Diet excluded other
nuts, dried fruit,
prebiotic or probiotic
foods or
supplements
Dietary fibre intake:
approximately
10 g/d(73). NS
change during study
Isoenergetic standard
American diet (15 %
PRO, 32 % fat,
53 % CHO)
Almonds substituted
for base diet foods
Dietary fibre intake: NR

Diet of participants;
fibre intake
Compliance to diet

Compliance
assessed via daily
and weekly
questionnaires,
and three
unannounced
dietary recalls
from each
intervention period
Mean almond
consumption:
adults: 41·7 g/d,
children: 15·0 g/d

Compliance
assessed via
daily
questionnaire,
results NR
Supervised feeding
for breakfast and
dinner. Lunch
and weekend
meals provided to
participants and
consumed offsite

Compliance
assessed via
self-reported
weekly food
diaries and
weighing of
returned
hazelnuts, results
NR

No nuts

No nuts

N/A

Control
group

Self-sampled, stored
at –70°C within
6 h of defecation

Self-sampled, stored
at –80°C

Self-sampled,
refrigerated and
delivered to the
lab within 24 h,
where stored
at –80°C until
analysis

Stool collection,
temp and storage

Bacterial (16s rRNA
gene sequencing,
V4 region)
Archaeal (V3–V4
region)
Fungal (ITS1–ITS4)
Illumina Miseq
Taxonomy database:
GreenGenes
(bacterial /
archaeal) and
UNITE OTU ITS
12_11 (fungal)
16s rRNA gene
sequencing
(V1–V3 region)
Illumina Miseq
Taxonomy database
NR

16s rRNA gene
sequencing
(V3–V4 region)
Illumina Miseq
Taxonomy database:
GreenGenes

Method of microbiota
determination and
taxonomy database

Diversity metrics

α-Diversity: NS
(Shannon and
inverse
Simpson’s
indexes, Chao-1
index)
β-Diversity: NR

α-Diversity: NS
(α-Diversity test
NR)
β-Diversity: NS
(weighted and
unweighted
UniFrac
distances;
statistical test or
P value NR)

α-Diversity: NS
(Simpson and
Shannon
indexes, Chao-1)
β-Diversity: NS
(ANOSIM based
on weighted and
unweighted
UniFrac metrics,
P value NR)
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n 18 almond study;
age 56·0 (SEM
8·6) years (44 %);
n 16 pistachio
study; age 50
(range 29–64)
years (50 %)

Ukhanova et al.(34)
(USA)

Population; BMI (kg/m )

Healthy non-smokers, BMI
Almond group: 27·4
(SEM 4·2); pistachio
group: 27·9 (range
20·8–34·5)

Healthy adults, BMI 25·3
(almond group), 25·6
(cracker group)

2

RCT-C
Feeding trial
Level II

Parallel design RCT
Free-living trial
Level II

Study design and
NHMRC level of
evidence

Intervention
period: 18 d
Washout period:
minimum
2 weeks

Intervention
period: 6 weeks

Study duration
and washout
period

NR

NR

Antibiotic/probiotic use

Almonds (whole, raw)
or pistachios
(whole, raw) 43 g or
85 g/d (equal to 1·5
or 3 servings/d)

Almonds, whole, dry
roasted
57 g/d

Nut type and format;
dose (g/d)
Diet recommendations
not provided;
however, both
groups advised to
avoid consumption
of other nuts or
seeds during the
intervention period
Dietary fibre intake:
Almond group:
mean 12·5 g/d at
baseline, NS
change during
study
Cracker group: mean
13·6 g/d at baseline,
NS change during
study
Isoenergetic standard
American diet fat:
fibre ratio matched
between diets.
Macronutrient
distribution NR
Almonds/pistachios
substituted for base
diet foods
Dietary fibre intake:
Pistachio group: 32·7 g
(0 g pistachios/
daily), 35·2 g (1·5 oz
pistachios/daily)
and 37·6 g (3 oz
pistachios/daily)
Almond group: 8·5 g/
100 g food (0 g
almonds/daily),
10·2 g/100 g food
(almond treatment
group)

Diet of participants;
fibre intake
Compliance to diet
Compliance
assessed via
weekly 24-h
dietary
assessment tool.
Participants
consumed
snacks on
average 6 d/week
during
intervention
Supervised feeding
of nuts and
crackers during
weekdays
(excluding
weekends and
5-d spring break)
Compliance
assessed via
daily
questionnaire,
results NR
Supervised feeding
for breakfast and
dinner. Lunch
and weekend
meals provided to
participants and
consumed offsite
No nuts

Graham
crackers
(77·5 g/d)

Control
group

Self-sampled, stored
on ice and
delivered to lab
usually within 4 h
of defecation.
Stored at –80°C
until analysis

Self-sampled; stored
at –80°C

Stool collection,
temp and storage

Bacterial (16s rRNA
gene sequencing,
V1–V3).
Fungal (IS4–IS5)
Sequencer: 454
pyrosequencing
Taxonomy database:
GreenGenes
(bacterial)
Fungal taxonomy
database NR

16s rRNA gene
sequencing
(V4–V5 region)
Illumina Miseq
Taxonomy database:
GreenGenes

Method of microbiota
determination and
taxonomy database

Diversity metrics
α-Diversity:
significant
increase between
groups (Shannon
index, Chao-1
index), and
significant
decrease
(Simpson’s index)
β-Diversity:
significant
differences
between groups
(PERMANOVA
using unweighted
UniFrac and
Bray-Curtis;
P < 0·05)
α-Diversity: NS
(Chao-1)
β-Diversity: NS
(mean UniFrac
distances, PCoA
plot based on
UniFrac analysis
(unweighted/
weighted not
specified)
Statistical test or
P value NR)

RCT-C, randomised controlled trial (cross-over); NHMRC, National Health and Medical Research Council; NR, not reported; PRO, protein; CHO, carbohydrate; OTU, operational taxonomic unit; PCoA, principal coordinate analysis; RCT, randomised controlled trial;
UM, urolithin metabotype.
* ‘Feeding trial’ as described above relates to trials in which 100 % of all food consumed during the study duration is provided to participants.
† This study also used fifteen age-matched normolipidaemic controls which were not included in the analysis.

n 73, aged
18–19 years
(56 %)

Sample size (n),
mean age (years),
(% female)

Dhillon et al.(33)
(USA)

Reference
(country)

Table 1. (Continued )
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Table 2. Significant shifts in the gut microbial composition following nut intake
Almonds

Walnuts

↓Actinobacteria(31)

↑Firmicutes(27)
↑Actinobacteria(29)
↓Actinobacteria(27)
↓Bacteroidetes(29)

Mixed (almonds/pistachios)

Phylum

Order
↑Unclassified member of
RF39(33)
Family
↓Unclassified member of
S24.7(33)

↑Coriobacteriaceae(29)‡
↓Lachnospiraceae(29)†

↑Clostridium(31)
↑Roseburia(31)
↑Dialister(31)
↑Lachnospira(3,31)
↓Bifidobacterium(31)
↑Oscillospira(31)
↓Parabacteroides(31)
↓Alistipes(33)
↓Butyricimonas(33)
↓Odoribacter(33)

↑Faecalibacterium(27)
↑Clostridium(27)
↑Roseburia(27)
↑Dialister(27)
↑Coprococcus(29)
↑Collinsella(29)
↑Bifidobacterium(29)‡
↓Bifidobacterium(27)
↑Blautia(29)‡
↓Oscillospira(27)
↓Ruminococcus(27)
↓Dorea(27)

Genus

Species
↓Bacteroides fragilis(33)
OTU

↓2 unclassified OTU
(Ruminococcaceae)(28)
↑Unclassified OTU (Bifidobacterium)(28)
↓Unclassified OTU (Blautia)(28)
↓Unclassified OTU (Anaerostipes)(28)

Almond:
↓Unclassified member closest to Clostridium sp.
ASF356(34)
↓Unclassified OTU (Candida tropicalis)(34)
↓Unclassified OTU (uncultured soil fungus)(34)
Pistachio:
↓Unclassified member closest to Firmicutes DJF VP44(34)
↓Unclassified OTU (Aspergillus fumigates)(34)
↓Unclassified OTU (Penicillium roqueforti)(34)
↓Unclassified OTU (Penicillium commune)(34)
↓Unclassified OTU (uncultured compost fungus)(34)
↓Unclassified OTU (Saccharomyces cerevisiae)(34)
↓Unclassified OTU (Candida sake)(34)
↓Unclassified OTU (Dipodascus capitatus)(34)

↓, Reported decrease in abundance/relative abundance; ↑, reported increase in abundance/relative abundance; OTU, operational taxonomic unit.
† Results for UM-A only.
‡ Results for UM-B only.

remaining two studies(29,32) found to be of neutral quality (online
Supplementary Data 2).

Microbiota diversity metrics and bacterial composition,
by nut type
Walnuts. Following consumption of 42 g of walnuts per d for
3 weeks, Holscher et al.(27) found no significant shifts in
α-diversity, a measure of within-sample diversity; however, bacterial communities were significantly affected by walnut consumption when β-diversity, a measure of microbial dissimilarity
between samples was analysed, as evidenced by a weighted principal coordinate analysis of UniFrac distances (P = 0·03). No significant differences in fungal or archaeal abundances were found
following walnut intake. A significant decrease in the relative
abundance of Actinobacteria was observed, with the relative
abundance of Firmicutes significantly increasing. At the genus
level, an increased relative abundance of the genera

Faecalibacterium, Clostridium, Roseburia (Clostridium clusters
XIVa and IV) and Dialister (49–160 % higher relative abundance)
was found, whereas the relative abundances of the genera
Ruminococcus, Dorea, Oscillospira and Bifidobacterium were
significantly decreased (16–38 % lower relative abundance).
Utilising 43 g of walnuts per d over an 8-week period,
Bamberger et al.(28) reported a significant shift in β-diversity only.
Using the generalised UniFrac distance metric and the
PERMANOVA statistical test, significant dissimilarity of approximately 5 % between the walnut and control groups (P = 0·02)
was found. No significant differences in predominant phyla or
the Firmicutes:Bacteroidetes ratio were observed. Significant
shifts in the relative abundance could be seen in four OTUs,
which are clusters of similar sequences used to categorise bacteria, of the phyla Firmicutes and one OTU of the phyla
Actinobacteria, which decreased. A significant increase was
found in two unclassified OTUs from the Ruminococcaceae family (P < 0·02), as well as an increase in an OTU from the
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Bifidobacterium genus (P < 0·02). A significant decrease was
found in the relative abundance of two OTUs, Anaerostipes
(P < 0·01) and Blautia (P = 0·04) from the Lachnospiraceae
family.
Garcia-Mantrana et al.(29) examined the effects of 33 g walnuts per d for 3 d on the gut microbiota, reporting results considering all participants, as well as according to the urolithin
metabotype (UM) of participants, a measure of how ellagitannins
metabolise to urolithins via the gut microbiota. According to their
urinary urolithin concentrations, participants were classified as
either UM-A (characterised by the production of urolithin-A),
UM-B (characterised by the production of urolithin-B) or
UM-0, whereby no urolithins were produced. Local diversity
(Chao-1 index) significantly decreased for both UMs after walnut
consumption and a redundancy analysis of all individuals
revealed that bacterial communities were significantly affected
by walnut intake (P = 0·001). However, when results were
reported according to UM, these shifts were only significant
for UM-B (P = 0·017), suggesting that UM-B was likely a driver
of overall significance. Considering the microbial composition,
walnut intake significantly decreased the relative abundance
of Bacteroidetes, while increasing the abundance of
Actinobacteria. Participants classed as UM-A exhibited a significant decrease in the Lachnospiraceae family, as well as a significant increase in the genera Coprococcus and Collinsela.
Participants classed as UM-B exhibited a significant increase in
the Coriobacteriaceae family, as well as significant increases in
the genera Coprococcus, Collinsella, Bifidobacterium and
Blautia.

Almonds. Dhillon et al.(33) examined the effects of 57 g roasted
almonds intake on the gut microbiota over 6 weeks, with graham
crackers being given to the control group. When considering
α-diversity, almond feeding resulted in significant increases in
the Chao-1 index, observed OTUs and Shannon index, while
the Simpson’s index was significantly decreased. Similarly, significant differences in β-diversity between treatment groups
were identified according to unweighted UniFrac distance and
Bray-Curtis dissimilarity metrics. A significant increase was
found in bacteria belonging to the RF39 order, as well as a significant decrease in bacteria belonging to the S24.7 family. At the
genus level, a significant decrease in Alistipes, Butyricimonas
and Odoribacter was observed, with a significant increase in
the genera Lachnospira. At the species level, a 48 % decreased
relative abundance of Bacteroides fragilis was reported.
Holscher et al.(31) utilised 42 g of almonds per d in varying
forms over five 3-week diet periods (whole, raw, whole dry
roasted, chopped, dry roasted and dry roasted almond butter),
finding no significant shifts in microbial diversity measures.
Further, no significant differences in fungal or archaeal abundances were found. Using pooled data, there were no significant
differences in the Firmicutes:Bacteroidetes ratio; however, a significant decrease in the relative abundance of Actinobacteria was
observed. Additionally, results revealed an increased relative
abundance of the genera Roseburia, Clostridium, Dialister
and Lachnospira. A decreased relative abundance of
Parabacteroides and Bifidobacterium was also observed.
When differentiating results by the impact of almond processing,

it was found that chopped almonds increased the relative abundance of Lachnospira, Roseburia and Oscillospira, whole
roasted almonds increased the relative abundance of
Lachnospira and whole raw almonds increased the relative
abundance of Dialister, with no difference between almond butter and controls.
Using both adult and children subjects, Burns et al.(32) used
almonds (an option of whole raw almonds or almond butter
equivalent) over two 3-week diet periods, with adults consuming 43 g/d and children 14 g/d. The present study found no significant change in microbial diversity or significant shifts at the
phylum level. However, significant differences in the prevalence
of unclassified bacterial signatures at the genus and species level
were reported.

Hazelnuts. Gargari et al.(30) investigated the effects of nut consumption on the microbiota over an 8-week period in both children and adults, using 0·43 g of hazelnuts per d per kg of body
weight, up to a maximum of 30 g of hazelnuts per d. This was the
only study to find no statistically significant differences in microbial diversity or composition of the gut microbiota.

Mixed intervention (almonds þ pistachios). Using a randomised, cross-over design, Ukhanova et al.(34) investigated the
effects of both almond and pistachio consumption on the gut
microbiota, utilising 0, 43 or 85 g/d (equal to 0, 1·5 or 3 serves)
for three 18-d feeding periods. While no significant changes in
α- or β-diversities were reported, the study did report the
pistachio-consuming group to have a greater mean UniFrac distance (unspecified if weighted or unweighted metric used) compared with the almond-consuming group. This suggests that
pistachios may have had a greater impact on the overall gut
microbiota composition compared with almonds. While many
OTUs were affected by nut consumption, only two were significantly decreased: one unspecified OTU closest to the Firmicutes
bacterium DJF VP44 and the other unspecified OTU closest to
Clostridium sp. ASF 356. Nut consumption did not significantly
affect the proportion of the most dominant OTUs. As the present
study also sequenced fungal DNA, it was found that while no
fungal OTU was significantly increased, various fungal OTUs
decreased in proportion (P < 0·01) with nut consumption.

Discussion
To our knowledge, this is the first study to systematically explore
the overall microbiota-related changes related to nut consumption. This review establishes that while the evidence base is
small, intake of nuts in the diet can exert a modulatory effect
on the gut microbiota; however, the exact effects were inconclusive across studies.
Microbial diversity has been shown to be a key predictor of
gut health, as greater diversity often equates to greater resilience
of the community to recover from or adjust to disturbances(41).
On the contrary, a loss of species diversity and an imbalance
in the gut’s microbial community, or ‘dysbiosis’, has commonly
been found in several disease states(9,42). The present systematic
review found that nut intake may have a modest effect on the
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diversity of the gut microbiota, with two(29,33) of the eight total
studies reporting a significant change in α-diversity (one showing a decrease in diversity(29)), and four(27–29,33) reporting a significant change in β-diversity. The lack of effect on α-diversity
found in this review is similar to the results of another systematic
review on dietary fibre(14), where short-term feeding studies of
dietary fibre in various forms did not increase α-diversity.
Furthermore, these findings are also comparable to other dietary
intervention studies using whole grains(43,44). Interestingly, one
study(29) included in this review observed a decrease in
α-diversity following a 3-d walnut feeding intervention, a result
comparable to findings from a short-term dietary intervention
advising increased fibre intake(45). The researchers suggested
this temporary reduction in diversity may be due to the rapid
dietary change causing disruption to the microbial composition,
termed the ‘shock effect’. However, these results are in contrast
to previous observational studies that explore the relationship
between overall dietary pattern and gut microbiota diversity.
For example, adherence to the Mediterranean diet has
been associated with increased gastrointestinal bacterial
α-diversity(46,47), a finding of particular relevance given that nuts
are a key component of this dietary pattern. Given that it has
been shown that diet-induced shifts in the gut microbiota occur
within 3–4 d after a change in diet(48), the discrepancies observed
between the short-term interventional trials included in this
review and previous observational studies which assess habitual
diets are unlikely due to the study duration alone. Rather, the discrepancies might also be explained by the synergistic effect of an
overall healthy dietary pattern, which appears to be a greater
determinant of gastrointestinal health than just foods or nutrients
in isolation.
Given the variation in the composition of different nut types,
consideration of study results by nut type was warranted.
Different nut types offer unique nutritional profiles, with altered
ratios of fibre, proteins, fat, micronutrients and other bioactive
molecules including polyphenols. Of all the nuts investigated
in the review, walnuts appeared to more frequently explain variations in the overall gut microbial composition between study
participants, with all three of the walnut studies reporting a significant shift in relevant β-diversity metrics. While it is difficult to
draw conclusions from this due to the small sample size, the
unique nutritional composition of walnuts as a potential modulator of the gut microbiota should be considered and further
explored in larger interventional trials. For example, walnuts
have a particularly high ellagitannin (a type of polyphenol,
the basic structure being ellagic acid) content compared with
other nuts(49). It has been shown that gastrointestinal bacteria
can metabolise ellagic acid to produce urolithins, which can
have beneficial vascular and anti-inflammatory effects(50,51),
although studies supporting the role of ellagitannins as a prebiotic are inconclusive(52,53). Further, it has been shown that different UMs can affect the metabolism and bioactivity of
polyphenols, as demonstrated by Garcia-Mantrana et al.(29).
Walnuts are also particularly rich in the n-3 essential fatty acid
α-linolenic acid(54). Preliminary research on n-3 supplementation in humans has found these fatty acids to exert significant
effects on gut microbial composition, with the authors concluding n-3 PUFA may be classified as prebiotics(26). It should be
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acknowledged that much of this research was performed using
EPA and DHA, which may be synthesised, albeit often inefficiently, from α-linolenic acid (55). As a result, the extent to which
α-linolenic acid acts as a possible modulator of the gut microbiota remains still unclear.
In the present review, alterations in the gut microbiota profile were reported across a range of different phylogenic categories, although a lack of consistency across studies was
observed. Nevertheless, some interesting patterns were
observed relating to Bifidobacterium spp. and the SCFA butyrate, which warrants further discussion. Members of the genus
Bifidobacterium are normal inhabitants of the human gastrointestinal tract and have demonstrated positive health benefits(56),
largely due to their production of acetate, which has antiinflammatory effects and is used by cross-feeding species as
a co-substrate for the production of butyrate(57). Additionally,
research has shown that the loss of Bifidobacterium species in
the gastrointestinal tract has been associated with poor bowel outcomes(58). Given that previous research has found an increased
abundance of Bifidobacterium with increased fibre(14) and polyphenol(59,60) intake, the addition of nuts to the diet may have been
expected to produce a bifidogenic effect; however, this effect was
inconsistent. Rather, two studies(27,31) reported a decreased
abundance of Bifidobacterium, one(29) reported a significant
increase in Bifidobacterium for UM-B (when stratified by UM),
and one(28) found an increase in one OTU from the
Bifidobacterium genus. The possible detrimental impact of
walnut consumption on Bifidobacterium may be explained by
inhibition of Bifidobacterium animalis spp. lactis in the presence
of ellagic acid. However, this finding is not universal to the
Bifidobacterium genus and appears to be species-specific(61).
Further, this hypothesis would not explain the findings of
Holscher et al.(31), which observed a decreased abundance of
Bifidobacterium following almond consumption. One significant
gap in the evidence base which may help explain these findings is
the use of more sophisticated multi-omic methods (e.g. shotgun
sequencing and metabolomics), a crucial step in explaining both
the functional potential of the microbiota and the types of metabolites these microbes can produce.
Findings of the present review are in contrast to the results of
a recent review by So et al.(14), which found that prebiotic fibre
supplementation consumption increased Bifidobacterium
species. Interestingly, subgroup analysis which separated the
effects of isolated fibres from whole foods found that
whole-food intervention of mostly grains and cereals had no
effect on Bifidobacterium abundances(14). However, the
impact of whole foods v. isolated food components on
Bifidobacterium populations is not consistent across studies.
Mandalari et al.(62) highlighted the likely importance of using
whole-food interventions over isolated fibres, demonstrating
that when almonds were consumed with all constituent parts
present (in comparison with almonds with the lipid content
removed), a significant increase in the abundance of
Bifidobacterium was observed. Taken together, these results
suggest a lack of consistency for the effects of whole foods
on the gut microbiota, highlighting the need for further research
exploring the comparative effect of whole foods and food
constituents.
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The SCFA butyrate is mainly produced by members of the
Firmicutes family including Roseburia spp. Lachnospira spp.
and Faecalibacterium prausnitzii, which belong to the clostridium clusters XIVa and IV(63). Butyrate is a major source of energy
for the colonic epithelial cells and has many well-documented
health effects, including the inhibition of colonic carcinogenesis
and acting as an anti-inflammatory agent(64). The present review
found two studies(27,31) to report a significantly increased abundance of Clostridium and Roseburia, another two studies(31,33) to
report a significantly increased abundance of Lachnospira and
one study(34) to report a significant increase in an OTU closest
to Clostridium sp. ASF-356. Studies in vitro have found that
finely ground almonds increase concentrations of butyrate(62)
and that Roseburia may be a major contributor to the
butyrate-producing capacity of the gastrointestinal tract(65). As
an increased abundance of specific butyrate-producing species
was observed in the included trials listed above, it may be
inferred that this potentially resulted in a butyrogenic effect,
although further research utilising metabolomic analysis is
required to confirm this. In contrast to these findings, one
study(27) included in the review did report finding no difference
in the predicted number of bacterial butanoate metabolism
genes following walnut consumption, potentially explained by
a proportionate decrease in other butyrate-producing species
during the feeding period. Indeed, considering changes in the
microbiota as a whole may be a better indicator of the overall
metabolomic capacity of the microbiota, rather than focusing
on the isolated microbial shift in individual taxa.
In addition to bacteria, the present review also summarised
the overall effects of nut intake on fungal and archaeal populations, providing a more comprehensive picture of the human gut
microbiota. While it has previously been reported that dietinduced shifts can modulate the populations of these
microbes(66), the review found no significant changes to the
diversity or the relative abundance of archaea, with only one
study(34) to report a decrease in various fungal OTUs following
nut intake. The small sample size of the review may account for
the differences observed in these results, as only one study
sequenced fungal DNA(34) and two studies sequenced both fungal and archaeal DNA(27,31). Further research in this area is
needed in order to form a more comprehensive understanding
of fungal and archaeal activity with nut intake.
While exploring shifts in the microbiota according to nut type
was the main focus of the review, other commonalities between
studies were also investigated to identify patterns in results. One
study characteristic of interest was the feeding method utilised.
For example, three(27,31,34) of the eight studies were classified as
complete feeding trials, whereby all food provided to participants was controlled (as opposed to free-living trials where nuts
were often administered alongside general dietary recommendations). Interestingly, while shifts in microbial diversity were
negligible (only one of the three studies reported a change in
β-diversity), shifts in bacterial composition were notable. In particular, two studies(27,31) reported an increase in Clostridium,
Roseburia and Dialister, all of which are known to be capable
of producing SCFA(67,68). In both studies, a run-in period of 9 d

was used to allow for the adaptation of the participant’s gut
microbiota following the change in habitual diet, increasing
the likelihood of these changes being attributable to nut intake.
While the small sample size limits the broader interpretation of
these findings, these results highlight the importance of controlling for participants’ background diet as a significant variable.
This review followed a robust methodology, including prospective registration of the review protocol and duplicate screening and inclusion of articles. Additionally, the review only
included trials employing next-generation sequencing technology, to ensure the most comprehensive analysis of the microbiota reflecting current analytical techniques, and a means of
promoting homogeneity between results. The implementation
of this exclusion criteria did mean that the evidence base for
analysis was smaller, as trials utilising other microbial determination techniques were excluded (such as bacterial culturing and
fluorescence in situ hybridisation). As a limitation, the systematic
search was restricted to scientific databases, which may have
meant that unpublished studies were not detected. Further,
the present review did not assess the metabolomic capacity of
the gut microbiota including the measurement of SCFA, meaning
interpretation of results is limited due to the challenge of connecting microbial shifts to metabolic pathway activity and health
outcomes(69). The high level of heterogeneity between studies
should also be acknowledged, including the collection and
processing of biological samples, sequencing platform and computational pipelines used. Also, papers differed in their statistical
analysis and reporting of gut microbial data, including the presentation of findings for different diversity metrics or only at certain taxonomic levels. Well-designed interventional trials with
larger sample sizes, reproducible methods and reporting of
results are still needed to exemplify the exact effect of nuts on
the gut microbiota.
Despite the small number of studies in this review, a large
variation in results was observed. This may be due to the intrinsically complex nature of microbiome research, with marked
differences in the inter-individual variation of subject’s gut
microbiota previously observed(48). Despite strategies to
decrease this variation such as the use of cross-over study
designs and excluding participants with gastrointestinal disease
or those on recent antibiotic therapy, large variations in the composition and function of individual’s microbiota remain. Previous
research has indicated that an individual’s response to any
dietary intervention is largely dependent upon their established
gut microbiota(70). Given these findings, and the knowledge that
a patient’s habitual diet and food diversity is a major determinant
of their gut microbiota(71), a more rigorous screening and selection process including pre-intervention dietary analysis may be
warranted in an attempt to reduce the inter-microbial differences
of individual’s microbiota at baseline. In addition, several limitations in the design of several included studies may have
impacted results – for example, a lack of reporting of baseline
nut consumption. Therefore, robust study designs which take
into account an individual’s baseline dietary intake, as well as
considering inter-individual gut microbiota differences are
required.
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Conclusion
This review suggests that nut intake has the potential to yield a
modest effect on the gut microbiota, although the exact effects
are inconsistent across studies. Compared with other nut types,
walnuts appeared to be the strongest driver of overall gut microbial composition (β-diversity), which may be explained by their
unique nutritional composition. Walnuts are rich in polyphenols
and n-3 fatty acids, both of which have been found to have prebiotic properties. Overall, it appears gut microbial composition is
more affected by nut intake during short-term feeding trials than
overall microbial diversity, although the small sample size of this
review limits interpretation. Further, whether these compositional changes translate into tangible health outcomes remains
to be investigated, ideally with the use of more sophisticated
multi-omic methods, such as metagenomic and metabolomic
technology to evaluate the overall functional capacity of the
microbiota. Inconsistencies associated with trial design and
methodology, as well as inter-individual microbiota variances
and the vast number of potential confounding variables present
in this field of research further complicate interpretation of the
results. Future trials aiming to explore the influence of nut intake
on the gut microbiota must carefully consider study design,
ideally incorporating complete feeding methods with a single
food or nutrient modification. Additionally, an assessment of
habitual dietary pattern and baseline microbiota composition
is recommended in order to minimise the inter-individual composition of the gut microbiota.
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